| 000 | 01506 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515001540.0 | ||
| 264 | 0 | _c20051207 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0269-4727 | ||
| 024 | 7 |
_a10.1111/j.1365-2710.2005.00665.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, J W M | |
| 245 | 0 | 0 |
_aNesiritide utilization evaluation in a university teaching hospital. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cOct 2005 |
||
| 300 |
_a447-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrug Utilization |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHospitals, Teaching |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xeconomics |
| 650 | 0 | 4 |
_aVasodilator Agents _xeconomics |
| 700 | 1 | _aMerl, M Y | |
| 700 | 1 | _aNguyen, H M | |
| 700 | 1 | _aCaliendo, G C | |
| 700 | 1 | _aMeyers, J | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 30 _gno. 5 _gp. 447-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2710.2005.00665.x _zAvailable from publisher's website |
| 999 |
_c15797634 _d15797634 |
||